Sign in
Taking peopleNo phase

Long-term follow-up of eosinophilic esophagitis in children and adults in Italy

Follows children and adults with eosinophilic esophagitis to see how the disease progresses.

Key facts

Who runs it
Fondazione IRCCS Policlinico San Matteo di Pavia
Where
Italy2 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Natural History of Eosinophilic Esophagitis in Adult and Pediatric Population
Status
Recruiting
People taking part
200 people, planned
Started
1 Sept 2025
Expected to end
Dec 2027
Type of study
Observational, 2 groups
Record updated
29 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and adults with a confirmed diagnosis of eosinophilic esophagitis (EoE). EoE is an allergy-linked swelling of the food pipe. The study follows how the disease and its treatment response change over time.

Age
5 years and older
Sex
All sexes
Disease stage
An established diagnosis of eosinophilic esophagitis

Main reasons for not taking part

  • Under 5 years old
  • People who cannot read or write
  • People who do not want to take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • patients with an established diagnosis of Eosinophilic esophagitis
  • aged ≥5 years
  • who gave written informed consent

Who cannot take part

  • under 5 years old
  • Patients who are illiterate
  • Patients who are unwilling to participate

This trial is currently available in Italy.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Eosinophilic esophagitis (EoE) is a Th2-mediated disease induced by ingestion of ambiental and alimentary allergens. Incidence of EoE is increasing in recent years. Young male subjects are more often affected by EoE. Esophageal eosinophilic infiltrate causes different symptoms of esophageal dysfunction (i.e. dysphagia, food impaction, chest pain, heartburn). In pediatric population symptoms are nonspecific (failure to thrive, vomiting) and more common to be misdiagnosed.

Read full original descriptionShow less

Symptoms are commonly sporadic and underestimated by the patients. Therefore, specialistic evaluations are often delayed during the following months and years. Moreover, esophageal symptoms are often not investigated or associated with other diseases especially in pediatric population (i.e. gastroesophageal reflux disease). For this reason, diagnosis of EoE is often delayed. It is known from literature that diagnostic delay in EoE causes prolonged inflammation of the esophagus that may lead to esophageal fibrosis and stenosis with worsening of symptoms. Proton pump inhibitors (PPIs) and topical steroids are the first line medicines to induce EoE remission. Prolonged clinical remission is described in 60% of adult patients with PPIs. Recently orodispersible budesonide showed clinical remission after 1 year nearby in 90% of adult patients. Orodispersible budesonide is effective also in chidren with an efficacy in maintaining remission at lowest effective dosage after 60 weeks in around 78% of patients. Dysphagia Symptom Questionnaire (DSQ) is a validated tool used in order to measure clinical activity (dysphagia) in adult and pediatric patients with EoE. Italian version of the DSQ is not available in literature. Little is known in literature about the natural history of EoE patients, in particular about sustained clinical remission and appearance of complications (i.e. food impaction) during a prolonged follow-up period. Aim of our two-phase prospective study is to evaluate the clinical and endoscopic response at the current available therapies and the appearance of complications during a prolonged follow-up period in a cohort of adult and pediatric population.

The 2 groups in the trial

  • Adult cohort
  • Paediatric cohort

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Natural History of Eosinophilic Esophagitis in Adult and Pediatric Population: a Multicentric Prospective Study in Italy
Plain-language title
Long-term follow-up of eosinophilic esophagitis in children and adults in ItalyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
29 June 2026